Mantle cell lymphoma is an aggressive form of B-cell non-Hodgkin lymphoma (NHL). It is a relatively rare disease, constituting only about 6% of all NHL cases in the United States or about 3,000 cases per year.

The Mantle Cell Lymphoma Consortium (MCLC) was formed in January 2005 by the Lymphoma Research Foundation (LRF) and is composed of more than 100 laboratory and clinical scientists from North America and Europe focusing their research efforts on mantle cell lymphoma. The MCLC is a program designed to accelerate the pace of research in mantle cell lymphoma. Our goal is to identify effective and curative treatment strategies for mantle cell lymphoma by funding innovative clinical studies.

LRF's 6th MCL Consortium Scientific Workshop >>

To receive a copy of the Workshop summary, email ymaxwell@lymphoma.org with "MCL Workshop Summary" in the subject line.

Highlights from the LRF 2009 MCLC Scientific Workshop has been published in the March 2009 issue of Leukemia & Lymphoma (Vol. 50, No. 12, Pages 1937-1970). Traditionally accessible only to subscribers for one year, Leukemia and Lymphoma has agreed to make this report available to the public for one month. >> 

Featured Researcher

Dr. Brad Kahl, MCLC Executive Committee member, was recently named chair of the ECOG lymphoma committee. Read about his journey to this point.

Mantle Cell Lymphoma News & Updates

• LRF CDA results in clinical trial >>
• MCL Highlights from ASCO >>
• Lenalidomide produces high response rate >>
• LRF's 6th MCL Consortium Scientific Workshop >>
  
• What has the MCL Consortium been up to? >>
  
• MCL Consortium Chair discusses curent state of MCL >>
  
• Clinical Trial Update >>
  
• 30 Years of Progress >>

• Help patients and researchers find the most up-to-date and accurate information on MCL clinical trials in an easy to use format.
• Post news items concerning MCL.
• Support research into the treatment and cure of MCL by providing members of the LRF Mantle Cell Lymphoma Consortium (MCLC) a tool for exchanging ideas and information. The website will give MCLC members
  • An opportunity to post reports and publications to share with colleagues.
  • A communication tool that presents information and ideas as well as support to Consortium and MCL projects and meetings.
  • An interface linking researchers directly to the MCLC-ATCC Cell Bank.